Long-term complications after stent assist coiling dependent on clopidogrel response
Related Experiment Video
Updated: Oct 31, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Kenji Shoda1, Yukiko Enomoto2, Yusuke Egashira2
1Department of Neurosurgery, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan. sho_ken@gifu-u.ac.jp.
Insights
Dual antiplatelet therapy (DAPT) after stent-assisted coiling is linked to delayed hemorrhagic events, particularly in clopidogrel responders. Careful consideration of DAPT duration is crucial to prevent these complications.
Area of Science:
- Neurosurgery
- Interventional Neuroradiology
- Cardiology
Background:
- Dual antiplatelet therapy (DAPT) is essential for stent-assisted coiling procedures.
- Long-term DAPT use carries a risk of hemorrhagic complications.
- Understanding clopidogrel reactivity is key to managing these risks.
Purpose of the Study:
- To investigate the relationship between clopidogrel reactivity and post-procedure complications.
- To compare hemorrhagic and thrombotic event rates in patients with different clopidogrel response levels.
- To assess the impact of clopidogrel response on hemoglobin levels post-procedure.
Main Methods:
- Retrospective analysis of 61 patients undergoing stent-assisted coiling with DAPT.
- Clopidogrel reactivity assessed using VerifyNow assay, defining hypo-responders (PRU≥208) and responders (PRU<208).
- Comparison of acute (≤30 days) and delayed (>30 days) hemorrhagic/thrombotic events and hemoglobin changes.
Main Results:
- Hemorrhagic events occurred more frequently in responders during the delayed phase (20.0% vs. 2.78%, p=0.037).
- Significant hemoglobin drops were observed in responders compared to hypo-responders in both acute and chronic phases.
- No significant difference in thrombotic events was found between the groups.
Conclusions:
- Long-term DAPT following stent-assisted coiling is associated with delayed hemorrhagic events.
- Clopidogrel responders are at higher risk for these delayed hemorrhagic events.
- DAPT duration requires careful consideration in clopidogrel responders to mitigate hemorrhagic risks.
Background:
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and complications.
Methods:
Patients who underwent stent assisted coiling for unruptured aneurysms or previously treated aneurysms and received periprocedural DAPT in our institution between August 2011 to March 2020 were included. Platelet reactivity for clopidogrel was measured by VerifyNow assay system, and we defined the cut off value of P2Y12 Reaction Units (PRU) at 208 and classified patients as hypo-responders (PRU≧208) or responders (PRU<208). The rates of hemorrhagic and thrombotic events within 30 days (acute phase) and 30 days after the procedure (delayed phase) were compared between the two groups. Furthermore, changes in hemoglobin levels were measured before and after the procedure and at chronic stages (1 to 6 months thereafter).
Results:
From 61 patients included in this study, 36 patients were hypo-responders and 25 patients were responders. Hemorrhagic events occurred 8.0% only in responders in the acute phase (p = 0.16), and 2.78% in hypo-responders and 20.0% in responders in the delayed phase (p = 0.037). Changes in hemoglobin levels before and after the procedure were 1.22 g/dl in hypo-responders and 1.74 g/dl in responders (p = 0.032) while before the procedure and chronic stages they were 0.39 g/dl in hypo-responders and 1.39 g/dl in responders (p < 0.01). Thrombotic events were not significantly different between the two groups.
Conclusion:
Long term use of DAPT after stent assisted coiling is related to hemorrhagic events in the delayed phase. Preventing for hemorrhagic events, the duration of DAPT should be carefully considered in clopidogrel responders.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

